Cilazapril

Modify Date: 2024-01-02 18:23:07

Cilazapril Structure
Cilazapril structure
Common Name Cilazapril
CAS Number 88768-40-5 Molecular Weight 417.49900
Density 1.26g/cm3 Boiling Point 598.1ºC at 760 mmHg
Molecular Formula C22H31N3O5 Melting Point 95-97ºC
MSDS N/A Flash Point 315.5ºC

 Use of Cilazapril


Cilazapril is a angiotensin-converting enzyme (ACE) inhibitor used for the treatment of hypertension and congestive heart failure.Target: ACECilazapril is a new nonthiol group containing angiotensin converting enzyme (ACE) inhibitor. Cilazapril has been investigated in more than 4000 patients with all degrees of hypertension, as well as in the special patient groups such as the elderly, renally impaired, and patients with concomitant diseases, such as congestive cardiac failure or chronic obstructive pulmonary disease [1]. Cilazapril is a very potent and highly effective converting enzyme inhibitor. Doses well below 5 mg/day will probably suffice for therapeutic efficacy [2].

 Names

Name (4S,7S)-7-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-6-oxo-1,2,3,4,7,8,9,10-octahydropyridazino[1,2-a]diazepine-4-carboxylic acid
Synonym More Synonyms

 Cilazapril Biological Activity

Description Cilazapril is a angiotensin-converting enzyme (ACE) inhibitor used for the treatment of hypertension and congestive heart failure.Target: ACECilazapril is a new nonthiol group containing angiotensin converting enzyme (ACE) inhibitor. Cilazapril has been investigated in more than 4000 patients with all degrees of hypertension, as well as in the special patient groups such as the elderly, renally impaired, and patients with concomitant diseases, such as congestive cardiac failure or chronic obstructive pulmonary disease [1]. Cilazapril is a very potent and highly effective converting enzyme inhibitor. Doses well below 5 mg/day will probably suffice for therapeutic efficacy [2].
Related Catalog
References

[1]. Szucs, T., Cilazapril. A review. Drugs, 1991. 41 Suppl 1: p. 18-24.

[2]. Nussberger, J., et al., Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers. J Cardiovasc Pharmacol, 1987. 9(1): p. 39-44.

 Chemical & Physical Properties

Density 1.26g/cm3
Boiling Point 598.1ºC at 760 mmHg
Melting Point 95-97ºC
Molecular Formula C22H31N3O5
Molecular Weight 417.49900
Flash Point 315.5ºC
Exact Mass 417.22600
PSA 99.18000
LogP 1.86220
Vapour Pressure 3.73E-15mmHg at 25°C
Index of Refraction 1.591
Storage condition 2-8°C

 Safety Information

Safety Phrases 22-24/25
RTECS MJ9650200

 Synthetic Route

 Synonyms

Ro 34-2848
(1S,9S)-9-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid
9(S)-[1-(S)-(ethoxycarbony)-3-phenylpropylamino]octahydro-10-oxo-6H-pyridazo[1,2-a][1,2]-diazepine-1(S)-carboxylic acid
(1S,9S)-9-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-10-oxooctahydro-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid
Cilazaprilum [Latin]
Cilazaprilum
MFCD08459332
Cilazil
EINECS 279-694-4
Cilazapril